PLD2 and central nervous system cancer: The activation of HIF-1α expression or activity by PLD2 has been reported in endothelial, glioma and renal cancer cells [65–67], but there is evidence of the opposite effect in HEK293 cells [68], suggesting that this feedback loop may work in specific contexts or cell types.